JP2020517738A5 - - Google Patents

Download PDF

Info

Publication number
JP2020517738A5
JP2020517738A5 JP2020507515A JP2020507515A JP2020517738A5 JP 2020517738 A5 JP2020517738 A5 JP 2020517738A5 JP 2020507515 A JP2020507515 A JP 2020507515A JP 2020507515 A JP2020507515 A JP 2020507515A JP 2020517738 A5 JP2020517738 A5 JP 2020517738A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
conhch
cme
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020507515A
Other languages
English (en)
Japanese (ja)
Other versions
JP7165721B2 (ja
JP2020517738A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/028986 external-priority patent/WO2018200425A1/en
Publication of JP2020517738A publication Critical patent/JP2020517738A/ja
Publication of JP2020517738A5 publication Critical patent/JP2020517738A5/ja
Application granted granted Critical
Publication of JP7165721B2 publication Critical patent/JP7165721B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020507515A 2017-04-24 2018-04-24 インフルエンザウイルス複製の阻害剤として有用なピロロピリミジン誘導体 Active JP7165721B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762489167P 2017-04-24 2017-04-24
US62/489,167 2017-04-24
PCT/US2018/028986 WO2018200425A1 (en) 2017-04-24 2018-04-24 Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication

Publications (3)

Publication Number Publication Date
JP2020517738A JP2020517738A (ja) 2020-06-18
JP2020517738A5 true JP2020517738A5 (cg-RX-API-DMAC10.html) 2021-06-10
JP7165721B2 JP7165721B2 (ja) 2022-11-04

Family

ID=62117141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020507515A Active JP7165721B2 (ja) 2017-04-24 2018-04-24 インフルエンザウイルス複製の阻害剤として有用なピロロピリミジン誘導体

Country Status (21)

Country Link
US (1) US11014941B2 (cg-RX-API-DMAC10.html)
EP (1) EP3615545B1 (cg-RX-API-DMAC10.html)
JP (1) JP7165721B2 (cg-RX-API-DMAC10.html)
KR (1) KR102598466B1 (cg-RX-API-DMAC10.html)
CN (1) CN110637022B (cg-RX-API-DMAC10.html)
AU (1) AU2018257778B2 (cg-RX-API-DMAC10.html)
CA (1) CA3059449A1 (cg-RX-API-DMAC10.html)
DK (1) DK3615545T3 (cg-RX-API-DMAC10.html)
EA (1) EA039181B1 (cg-RX-API-DMAC10.html)
ES (1) ES2901875T3 (cg-RX-API-DMAC10.html)
IL (1) IL269900B (cg-RX-API-DMAC10.html)
MX (1) MX393113B (cg-RX-API-DMAC10.html)
MY (1) MY199746A (cg-RX-API-DMAC10.html)
NZ (1) NZ757442A (cg-RX-API-DMAC10.html)
PH (1) PH12019502376B1 (cg-RX-API-DMAC10.html)
PL (1) PL3615545T3 (cg-RX-API-DMAC10.html)
SG (1) SG11201909478UA (cg-RX-API-DMAC10.html)
SM (1) SMT202100684T1 (cg-RX-API-DMAC10.html)
TW (1) TWI778052B (cg-RX-API-DMAC10.html)
WO (1) WO2018200425A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201906327B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020081751A1 (en) * 2018-10-17 2020-04-23 Cocrystal Pharma, Inc. Combinations of inhibitors of influenza virus replication
AU2019380421B2 (en) * 2018-11-13 2025-07-24 Cocrystal Pharma, Inc. Formulations of influenza therapeutics
KR102890026B1 (ko) * 2019-04-26 2025-11-24 닛산 가가쿠 가부시키가이샤 아릴술폰산 에스테르 화합물의 제조 방법
WO2022007966A1 (zh) * 2020-07-10 2022-01-13 四川海思科制药有限公司 Pb2抑制剂及其制备方法和用途
US12559745B2 (en) * 2020-11-23 2026-02-24 The Regents Of The University Of California Methods and compositions for linking RNA stem loops

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB278965A (en) 1927-03-24 1927-10-20 Gerhard Haar Improved agricultural plough
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4353656A (en) 1980-10-14 1982-10-12 Xerox Corporation Moving coil, multiple energy print hammer system including a closed loop servo
EP0069715B1 (en) 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
DK172541B1 (da) 1982-10-08 1998-12-07 Glaxo Group Ltd Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
US4501729A (en) 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
US4753788A (en) 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
AU6909091A (en) 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2379909C (en) 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US7252840B1 (en) 1999-08-25 2007-08-07 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US6632666B2 (en) 2000-01-14 2003-10-14 Biolife Solutions, Inc. Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002013897A2 (en) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalation device and method
CA2433335C (en) 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
CA2456292A1 (en) 2001-08-14 2003-02-27 Toyama Chemical Co., Ltd. Novel virus growth inhibitor and/or virucidal method, and novel pyrazine nucleotide or pirazine nucleoside analog
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
WO2005023335A2 (en) 2003-09-05 2005-03-17 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
ES2364340T3 (es) 2004-03-30 2011-08-31 Vertex Pharmaceuticals Incorporated Azaindoles útiles como inhibidores de jak y otras proteína quinasas.
NZ592968A (en) 2006-01-17 2012-08-31 Vertex Pharma Azaindoles substituted with either triazine or pyrimidine useful as inhibitors of janus kinases consisting of JAK1, JAK2, JAK3, and TYK2
GEP20207129B (en) * 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
NZ629996A (en) 2012-03-13 2016-10-28 Gilead Sciences Inc 2’- substituted carba-nucleoside analogs for antiviral treatment
HUE038820T2 (hu) 2013-11-13 2018-11-28 Vertex Pharma Eljárás influenzavírusok replikációjának inhibitorai elõállítására
SG11201701621YA (en) 2014-09-08 2017-03-30 Janssen Sciences Ireland Uc Pyrrolopyrimidines for use in influenza virus infection
CN105524067A (zh) 2014-09-28 2016-04-27 江苏柯菲平医药股份有限公司 4-取代吡咯并[2,3-d]嘧啶化合物及其用途
FR3039227B1 (fr) 2015-07-22 2019-12-27 Safran Aircraft Engines Aeronef comprenant un propulseur arriere carene avec stator d’entree a volets mobiles
EP3362451B1 (en) * 2015-12-09 2023-04-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
WO2017133664A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Bicyclic pyridine and pyrimidine derivatives and their use in the treatment, amelioration or prevention of influenza
WO2017133667A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyrimidine and pyridine derivatives and use in treatment, amelioration or prevention of influenza thereof
CN109071567B (zh) * 2016-05-19 2021-03-23 四川大学 抗流感小分子化合物及其制备方法和用途
DE102017000989A1 (de) * 2017-02-03 2018-08-09 Evonik Degussa Gmbh Verfahren zur Herstellung von Cyclododecanon

Similar Documents

Publication Publication Date Title
JP2015518004A5 (cg-RX-API-DMAC10.html)
JP2014505660A5 (cg-RX-API-DMAC10.html)
JP2021501756A5 (cg-RX-API-DMAC10.html)
JP2012505871A5 (cg-RX-API-DMAC10.html)
JP2022544714A5 (cg-RX-API-DMAC10.html)
JP2020510015A5 (cg-RX-API-DMAC10.html)
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2009529540A5 (cg-RX-API-DMAC10.html)
JP2017515844A5 (cg-RX-API-DMAC10.html)
JP2014500265A5 (cg-RX-API-DMAC10.html)
JP2017523225A5 (cg-RX-API-DMAC10.html)
JP2015509098A5 (cg-RX-API-DMAC10.html)
JP2010536887A5 (cg-RX-API-DMAC10.html)
JP2014500295A5 (cg-RX-API-DMAC10.html)
SI3024819T1 (en) Glyoxamide-substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis B
GEP20156250B (en) 1,3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
RU2013108865A (ru) Производные хинолина и содержащие их ингибиторы melk
JP2017523169A5 (cg-RX-API-DMAC10.html)
JP2015522650A5 (cg-RX-API-DMAC10.html)
JP2020507589A5 (cg-RX-API-DMAC10.html)
EA200970535A1 (ru) Антибактериальные производные хинолина
JP2015507636A5 (cg-RX-API-DMAC10.html)
JP2016529306A5 (cg-RX-API-DMAC10.html)
JP2018517753A5 (cg-RX-API-DMAC10.html)
RU2018142988A (ru) Производные пиридиндикарбоксамида в качестве ингибиторов бромодомена